alexa Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus | Open Access Journals
ISSN: 2475-3211
Journal of Diabetic Complications & Medicine
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus

Daniel Petrovič*

Institute of Histology and Embryology, University of Ljubljana, Korytkova 2, 1105 Ljubljana, Slovenia

Corresponding Author:
Daniel Petrovič
Faculty of Medicine, MD, PhD, FESC
Institute of Histology and Embryology
University of Ljubljana, Korytkova 2, 1105 Ljubljana, Slovenia
Tel: +38615437467
Fax: +38615437361
E-mail: [email protected]

Received Date: September 26, 2016; Accepted Date: September 28, 2016; Published Date: September 30, 2016

Citation: Petrovic D (2016) Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus. J Diabetic Complications Med 1: e102. doi: 10.4172/2475-3211.1000e102

Copyright: © 2016 Petrovic D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Diabetic Complications & Medicine

Editorial

It is generally accepted that beside cholesterol accumulation, chronic inflammation and immune system are very much involved in the pathogenesis of atherosclerosis [1]. A genetic variability of the candidate genes implicated in atherosclerosis (i.e. candidate genes of inflammation, oxidative stress, growth factors, renin-angiotensin aldosterone system, and so-forth) has so far been demonstrated in several reports to affect the development of atherosclerosis [2]. Genetic variability in the candidate genes implicated in atherosclerosis may alter their transcriptional activity and contribute to susceptibility to cardiovascular disease [3-11]. In the pathogenesis of atherosclerosis genetic, environmental, and epigenetic factors are involved [4,5].

Genetic and epigenetic factors may be studied with two main approaches, candidate gene approach and genome wide association study (GWAS) approach [4-9,11]. Candidate gene approach is hypothesis-driven approach, whereas in GWAS approach appropriate subset of patients (i.e. patients with coronary artery disease, myocardial infarction, T2DM, bronchial asthma, Crohn disease and so forth) are genetically analyzed and distribution of genotypes/alleles compared with appropriate control subjects [4-8].

In cardiovascular research, s great potential of systems-based methodologies has been demonstrated in several phenotypes, including atherosclerosis [4,5]. Omics data (genomics, proteomics, metabolomics, transcriptomics, epigenomics, nutriepigenomics) are becoming widely available by progress in high-throughput molecular profiling. However, integration between the omics data, biological sciences, clinical data and other clinical diagnostic modalities are going to be essential for the success of translation of integrative analysis of biological biomarkers into the clinical practice.

There are two non-invasive markers of carotid atherosclerosis available, carotid intima-media thickness (CIMT) and carotid atherosclerosis (demonstrated as number of affected segments of carotid arteries, the sum of plaques thickness). In last decade it has been accepted that CIMT is biologically distinct from atherosclerotic plaques, not really atherosclerosis, but both represent an indicator for cardiovascular risk [12]. In contrast, carotid plaques are a characteristic phenotype of atherosclerosis, not a simple continuum of CIMT progression, and predict the cardiovascular disease better than CIMT [12,13].

So far, several studies using either candidate gene approach or GWAS approach have been reported several genetic markers for either CIMT or subclinical carotid atherosclerosis, however most reports studied patients in general population, and only few enrolled subjects with type 2 diabetes mellitus (T2DM) [4-9,11]. It should be emphasized, however, that whatever approach (candidate gene or GWAS approach) may be used, crucial is well-designed and appropriately selected study group. Moreover, according to expected great increase in the incidence of T2DM in coming years, patients with T2DM should be studied more often.

In patients with T2DM, cardiovascular complications are reported about 15 years earlier than in the population without T2DM, and they have worse prognosis as well [14,15]. Beside traditional risk factors identified in the general population, such as arterial hypertension, dyslipidemia, cigarette smoking and parental history of cardiovascular diseases, T2DM and different genetical factors also contribute to the high prevalence of cardiovascular disease in patients with diabetes mellitus [14-16].

To conclude, good cooperation between clinicians, geneticists, biologists, epidemiologists, statisticians, and computing scientists are essential for advance of carotid artery disease and cardiovascular diseases in general [14-16]. Secondly, well-designed and appropriately powered studies are needed to enroll different subset of patients with different environmental and genetical background.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 8329
  • [From(publication date):
    September-2016 - Oct 21, 2017]
  • Breakdown by view type
  • HTML page views : 8231
  • PDF downloads :98
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords